Lysosomal control of plasma membrane -endoplasmic reticulum membrane contacts regulates neuronal excitability
Lysosomal control of plasma membrane -endoplasmic reticulum membrane contacts regulates neuronal excitability
批准号:
10622184
负责人:
Eamonn James Dickson
金额:
$26.67万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
关键词:
Alzheimer&aposs DiseaseAnimal BehaviorAttentionAutophagocytosisAwardBrainBrain MappingBrain regionCalciumCell membraneCellular MembraneCholesterolCholesterol HomeostasisChronicCommunicationDementiaDiseaseElectrophysiology (science)ElementsEndoplasmic ReticulumGatekeepingGenetic TranscriptionGolgi ApparatusHomeostasisInstructionIon ChannelKnowledgeLeadLinkLumen of the LysosomeLysosomesMembraneMetabolismMitochondriaModelingMolecularNerve DegenerationNeurodegenerative DisordersNeuronsNuclear Pore ComplexOpticsParkinson DiseaseReportingSeizuresShapesSignal TransductionSiteSymptomsSystemTestingToxic effectWorkbehavior testcholesterol transporterscytotoxicloss of function mutationlysosome membranemitochondrial membranemouse modelneuronal excitabilityneuropathologyneurotoxicnovelnovel therapeutic interventionprogressive neurodegenerationsuperresolution imaging
中文摘要
项目总结
英文摘要
Project Summary
Lysosomes are sophisticated and dynamic cellular signaling centers that control metabolism, gene transcription,
calcium (Ca2+) homeostasis, and autophagy. A key mechanism through which lysosomes communicate and
receive instruction is via transfer of cholesterol at ER–lysosome membrane contact sites. At these contacts the
Niemann Pick C1 cholesterol transporter (NPC1) facilitates the efflux of cholesterol out of the lysosome before
it is transferred to the ER for distribution to other cellular membranes. Thus, NPC1 is a key gatekeeper in
cholesterol metabolism. Further underscoring its importance, loss of function mutations in NPC1 lead to the
progressive neurodegenerative disorder, NPC disease. This fatal condition has no cure and is characterized by
the accumulation of cholesterol within lysosome lumen and the progressive neurodegeneration of several brain
regions that are accompanied by a host of devastating symptoms including seizures, psychiatric problems, and
dementia. Notwithstanding clear neuropathological consequences for cholesterol dysregulation in NPC disease,
the molecular mechanism(s) linking loss of NPC1 function to disease neuropathology are unknown. Recently
our group has reported that loss of NPC1 function results in (i) neuron hyperexcitability, (ii) reorganization of ER–
Lysosome, ER–Golgi, and ER–mitochondrial membrane contact sites, and (iii) induces neurotoxic increases in
mitochondrial Ca2+. Despite this crucial information there are critical gaps in our knowledge regarding (1) the
consequences of enhanced excitability in NPC disease, (2) how lysosomal cholesterol transport alters the
molecular elements and choreography at neuronal ER–plasma membrane (ER–PM) contact sites, and (3) if
plasma membrane ion channels or ER–PM junctions can be targeted to reduce mitochondrial toxicity and
increase neuron viability in NPC disease. Our central hypothesis is that loss of NPC1 function results in
aberrant remodeling of ion channel distribution and function at ER–PM contacts to drive cytotoxic increases in
mitochondrial Ca2+ leading to neurodegeneration. To test this hypothesis, we implement a multi-scale approach,
including super-resolution imaging, electrophysiology, optical mapping of brain excitability, novel murine models,
and animal behavior testing to rigorously investigate the mechanisms by which cholesterol efflux from the
lysosome tunes neuron viability. The fundamental importance and ubiquitous expression of the NPC cholesterol
transporter means we should pay particular attention to molecular elements and signaling cascades that are
modified by its activity. Investigating the relationship between cholesterol homeostasis and ion channel signaling
at ER–PM membrane contacts in NPC provides a testable model for examining the interdependence of
lysosomal cholesterol and ion channel activity and has broad implications for several fields and other cholesterol-
linked diseases such as Alzheimer’s and Parkinson’s.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity
-
批准号:10635208
-
项目类别:
-
资助金额:$165.05万
-
财政年份:2023
-
负责人:Eamonn James Dickson
-
依托单位:
Regulation of phosphoinositide metabolism and calcium dynamics in the neocortex
-
批准号:10635365
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2023
-
负责人:Eamonn James Dickson
-
依托单位:
Membrane contact sites regulate cellular excitability
-
批准号:10061627
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:Eamonn James Dickson
-
依托单位:
Membrane contact sites regulate cellular excitability
-
批准号:10302271
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:Eamonn James Dickson
-
依托单位:
Membrane contact sites regulate cellular excitability
-
批准号:10524750
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:Eamonn James Dickson
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: